FDA Authorizes KMT2A FISH Test as Companion Diagnostic for Acute Leukemia Therapy
The breakapart probe detects gene rearrangements in acute leukemia patients to identify candidates for menin inhibitor therapy.
Read MorePosted by CLP Edit Staff | Sep 23, 2025 | Leukemia |
The breakapart probe detects gene rearrangements in acute leukemia patients to identify candidates for menin inhibitor therapy.
Read MorePosted by CLP Edit Staff | Sep 22, 2025 | Leukemia |
MARLIN uses DNA methylation patterns and machine learning to classify leukemia subtypes, potentially accelerating treatment decisions.
Read MorePosted by CLP Edit Staff | Aug 15, 2025 | Cancer |
Dana-Farber Cancer Institute, Boston Children’s Hospital, and Broad Clinical Labs form BrightSeq collaborative to develop novel clinical diagnostic assays for rare pediatric cancers.
Read MorePosted by Editorial Staff | Jul 29, 2025 | Diagnostic Technologies |
Breath tests are increasingly being explored and implemented in clinical diagnosis, offering a non-invasive means to detect a variety of conditions like blood cancer, lung disease, lower respiratory tract infections, and gastroparesis.
Read MorePosted by Chris Wolski | Jul 1, 2025 | Molecular Diagnostics |
Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.
Read More